US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
CA1327010C
(en)
*
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
|
US6749864B2
(en)
*
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US5026560A
(en)
*
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
US5030447A
(en)
*
|
1988-03-31 |
1991-07-09 |
E. R. Squibb & Sons, Inc. |
Pharmaceutical compositions having good stability
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
JPH0768125B2
(ja)
*
|
1988-05-18 |
1995-07-26 |
エーザイ株式会社 |
酸不安定化合物の内服用製剤
|
WO1990013286A1
(fr)
*
|
1989-05-11 |
1990-11-15 |
Chugai Seiyaku Kabushiki Kaisha |
Preparation orale pouvant etre liberee dans une region appropriee de l'intestin
|
GR1002098B
(en)
*
|
1989-06-08 |
1995-12-28 |
Squibb & Sons Inc |
Pharmaceutical composition having good stability
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
PH27186A
(en)
*
|
1989-09-07 |
1993-04-16 |
Ciba Geigy Ag |
Double-coated granules of disodium pamidronate
|
KR930000861B1
(ko)
*
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
오메프라졸 직장투여 조성물
|
IT1245891B
(it)
*
|
1991-04-12 |
1994-10-25 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
|
IT1245890B
(it)
*
|
1991-04-12 |
1994-10-25 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
|
YU48263B
(sh)
*
|
1991-06-17 |
1997-09-30 |
Byk Gulden Lomberg Chemische Fabrik Gmbh. |
Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
HU9203780D0
(en)
*
|
1991-12-12 |
1993-03-29 |
Sandoz Ag |
Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
ZA937382B
(en)
*
|
1992-10-06 |
1994-04-29 |
Warner Lambert Co |
Novel composition for peroral therapy of cognitionimpairment and a process therefor
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
*
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
TW280770B
(sh)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
JPH07223970A
(ja)
*
|
1994-02-10 |
1995-08-22 |
Tanabe Seiyaku Co Ltd |
消化管内適所放出製剤
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
ATE206044T1
(de)
*
|
1994-07-08 |
2001-10-15 |
Astrazeneca Ab |
Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i)
|
US5508276A
(en)
*
|
1994-07-18 |
1996-04-16 |
Eli Lilly And Company |
Duloxetine enteric pellets
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
CN1093855C
(zh)
*
|
1995-09-21 |
2002-11-06 |
帕斯医药股份有限公司 |
新的含有对酸不稳定的奥美拉唑的组合物及其制备方法
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE512835C2
(sv)
*
|
1996-01-08 |
2000-05-22 |
Astrazeneca Ab |
Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
|
SE9602442D0
(sv)
*
|
1996-06-20 |
1996-06-20 |
Astra Ab |
Administration of pharmaceuticals
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
US6544523B1
(en)
*
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US5788987A
(en)
*
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
US5910319A
(en)
|
1997-05-29 |
1999-06-08 |
Eli Lilly And Company |
Fluoxetine enteric pellets and methods for their preparation and use
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
US6296876B1
(en)
*
|
1997-10-06 |
2001-10-02 |
Isa Odidi |
Pharmaceutical formulations for acid labile substances
|
US20050244497A1
(en)
*
|
1997-11-05 |
2005-11-03 |
Wockhardt Limited |
Delayed delivery system for acid-sensitive drugs
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
WO1999027917A1
(de)
*
|
1997-11-28 |
1999-06-10 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Arzneimittelzubereitung in tabletten- oder pelletform für säurelabile wirkstoffe
|
DE19752843C2
(de)
*
|
1997-11-28 |
2003-01-09 |
Byk Gulden Lomberg Chem Fab |
Arzneimittelzubereitung in Tabletten- oder Pelletform für Pantoprazol und Omeprazol
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
JP4127740B2
(ja)
*
|
1998-04-20 |
2008-07-30 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
安定化したベンズイミダゾール系化合物含有組成物
|
KR101032289B1
(ko)
|
1998-05-18 |
2011-05-06 |
다케다 야쿠힌 고교 가부시키가이샤 |
미세과립
|
UA69413C2
(uk)
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
US7122207B2
(en)
*
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
AUPP437698A0
(en)
|
1998-06-30 |
1998-07-23 |
Baumgart, Karl |
Methods for treatment of coronary, carotid and other vascular disease
|
UA73092C2
(uk)
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
DK1105105T3
(da)
|
1998-08-12 |
2006-07-17 |
Altana Pharma Ag |
Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
JP2002527066A
(ja)
|
1998-10-15 |
2002-08-27 |
カイロン コーポレイション |
転移性乳癌および結腸癌調節遺伝子
|
WO2000026185A2
(en)
*
|
1998-10-30 |
2000-05-11 |
The Curators Of The University Of Missouri |
Omeprazole solution and method of using same
|
TWI242000B
(en)
|
1998-12-10 |
2005-10-21 |
Univ Southern California |
Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
|
SI20109A
(sl)
*
|
1998-12-16 |
2000-06-30 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Stabilna farmacevtska formulacija
|
ATE408695T1
(de)
|
1998-12-16 |
2008-10-15 |
Novartis Vaccines & Diagnostic |
Menschliche cyclin-abhängige kinase (hpnqalre)
|
US6210716B1
(en)
*
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
US6197329B1
(en)
|
1999-05-03 |
2001-03-06 |
Drugtech Corporation |
Anti-nausea compositions and methods
|
EP1187601B1
(en)
|
1999-06-07 |
2005-07-27 |
ALTANA Pharma AG |
Novel preparation and administration form comprising an acid-labile proton pump inhibitor
|
IL130602A0
(en)
*
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
ES2168043B1
(es)
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
KR20020038759A
(ko)
|
1999-10-20 |
2002-05-23 |
다니구치 미즈오 |
벤즈이미다졸계 화합물 안정화 방법
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
WO2001051515A2
(en)
|
2000-01-10 |
2001-07-19 |
Chiron Corporation |
Genes differentially expressed in breast cancer
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
US6749867B2
(en)
|
2000-11-29 |
2004-06-15 |
Joseph R. Robinson |
Delivery system for omeprazole and its salts
|
DK1341528T3
(da)
|
2000-12-07 |
2012-03-26 |
Nycomed Gmbh |
Hurtigtopløsende tablet omfattende en syrelabil aktiv bestanddel
|
BR0115989A
(pt)
|
2000-12-07 |
2004-01-13 |
Altana Pharma Ag |
Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
|
PT1341524E
(pt)
|
2000-12-07 |
2011-12-30 |
Nycomed Gmbh |
Preparação farmacêutica na forma de uma pasta compreendendo um ingrediente activo lábil a ácido
|
US20020192299A1
(en)
*
|
2000-12-28 |
2002-12-19 |
Rajneesh Taneja |
Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
|
JP2002234842A
(ja)
*
|
2001-02-09 |
2002-08-23 |
Kyowa Yakuhin Kogyo Kk |
内服腸溶性製剤
|
AU2002252364B2
(en)
*
|
2001-03-13 |
2005-08-25 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
US20060127474A1
(en)
*
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
US7309783B2
(en)
*
|
2001-05-09 |
2007-12-18 |
The University Of Connecticut |
Mammalian early developmental regulator gene
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
US6543389B2
(en)
|
2001-06-26 |
2003-04-08 |
Pfizer Inc. |
Insecticidal pet collar
|
US8309118B2
(en)
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
MXPA04002977A
(es)
*
|
2001-09-28 |
2005-06-20 |
Johnson & Johnson |
Forma de dosificacion que contiene una composicion de confiteria.
|
EP2258351B1
(en)
*
|
2001-10-17 |
2013-06-19 |
Takeda Pharmaceutical Company Limited |
Granules containing lansoprazole in large amount
|
ES2198195B1
(es)
|
2001-12-18 |
2004-10-01 |
Laboratorios Del Dr. Esteve, S.A. |
Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
US20040082618A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Liquid dosage forms of acid labile drugs
|
US7429619B2
(en)
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
US20050191353A1
(en)
*
|
2002-08-16 |
2005-09-01 |
Amit Krishna Antarkar |
Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
|
EP1530460A2
(en)
*
|
2002-08-16 |
2005-05-18 |
Themis Laboratories Private Limited |
A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
|
US7135324B2
(en)
*
|
2002-09-04 |
2006-11-14 |
The University Of Connecticut |
Viral recombinases, related articles, and methods of use thereof
|
JP4169329B2
(ja)
*
|
2002-10-04 |
2008-10-22 |
村樫石灰工業株式会社 |
消石灰系塗材組成物
|
ES2534713T3
(es)
|
2002-10-16 |
2015-04-27 |
Takeda Pharmaceutical Company Limited |
Preparaciones sólidas estables
|
EP1556010A4
(en)
*
|
2002-10-31 |
2007-12-05 |
Supergen Inc |
PHARMACEUTICAL FORMULATIONS TARGETING SPECIFIC REGIONS OF THE GASTROINTESTINAL TRACT
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
US20070243251A1
(en)
*
|
2002-12-20 |
2007-10-18 |
Rajneesh Taneja |
Dosage Forms Containing A PPI, NSAID, and Buffer
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
US20040146558A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Kyowa Pharmaceutical Co., Ltd. |
Oral enteric-coated preparation
|
JP2006516574A
(ja)
|
2003-02-05 |
2006-07-06 |
テバ ファーマシューティカル インダストリーズ リミティド |
ランソプラゾール安定化方法
|
US20040248942A1
(en)
*
|
2003-02-20 |
2004-12-09 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
EP1617842A1
(en)
*
|
2003-04-22 |
2006-01-25 |
Dr. Reddy's Laboratories Ltd. |
Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these
|
ES2234393B2
(es)
*
|
2003-04-29 |
2006-09-01 |
Laboratorios Belmac, S.A. |
"formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
*
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
DE10341414A1
(de)
*
|
2003-09-05 |
2005-03-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
|
US20050053669A1
(en)
*
|
2003-09-05 |
2005-03-10 |
Boehringer Ingelheim International Gmbh |
Administration form for the oral application of poorly soluble acidic and amphorteric drugs
|
MXPA06003100A
(es)
*
|
2003-09-19 |
2006-06-20 |
Penwest Pharmaceuticals Co |
Formas de dosis de liberacion retardada.
|
US20050118267A1
(en)
*
|
2003-09-19 |
2005-06-02 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
WO2005046634A2
(de)
*
|
2003-11-14 |
2005-05-26 |
Siegfried Generics International Ag |
Magensaftresistente verabreichungsform
|
HU227317B1
(en)
*
|
2003-11-25 |
2011-03-28 |
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag |
Enteric coated tablet containing pantoprazole
|
CN1321642C
(zh)
*
|
2003-12-12 |
2007-06-20 |
南京长澳医药科技有限公司 |
泮托拉唑钠肠溶微丸
|
JP2007517038A
(ja)
*
|
2003-12-30 |
2007-06-28 |
ドクター レディズ ラボラトリーズ リミテッド |
薬学的組成物
|
EP1720527A2
(en)
*
|
2004-03-03 |
2006-11-15 |
Teva Pharmaceutical Industries Ltd |
A stable pharmaceutical composition comprising an acid labile drug
|
ES2407465T3
(es)
|
2004-03-29 |
2013-06-12 |
Galpharma Co., Ltd. |
Nueva proteína galectina 9 modificada y uso de la misma
|
US7491263B2
(en)
|
2004-04-05 |
2009-02-17 |
Technology Innovation, Llc |
Storage assembly
|
JP2007536349A
(ja)
|
2004-05-07 |
2007-12-13 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規の医薬剤形及び製造方法
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AU2005264864B2
(en)
|
2004-06-16 |
2011-08-11 |
Takeda Pharmaceutical Company Limited |
Multiple PPI dosage form
|
US20050281876A1
(en)
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
US8658216B2
(en)
|
2004-12-23 |
2014-02-25 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
MX2007008141A
(es)
*
|
2005-01-03 |
2007-12-10 |
Lupin Ltd |
Composicion farmaceutica de sustancias labiles en medio acido.
|
US20060165797A1
(en)
*
|
2005-01-12 |
2006-07-27 |
Pozen Inc. |
Dosage form for treating gastrointestinal disorders
|
WO2006087613A2
(en)
*
|
2005-02-02 |
2006-08-24 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions prepared by non-aqueous layering process
|
KR100570446B1
(ko)
*
|
2005-02-14 |
2006-04-12 |
지엘팜텍 주식회사 |
산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법
|
US20060210637A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Qpharma, Llc |
Stable tablet dosage forms of proton pump inhibitors
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
US20070015782A1
(en)
|
2005-04-15 |
2007-01-18 |
Eisai Co., Ltd. |
Benzimidazole compound
|
WO2006111853A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Aurobindo Pharma Limited |
Stable solid dosage forms of acid labile drug
|
US9040564B2
(en)
|
2005-04-28 |
2015-05-26 |
Eisai R&D Management Co., Ltd. |
Stabilized composition
|
EP1875911A4
(en)
*
|
2005-04-28 |
2010-03-03 |
Eisai R&D Man Co Ltd |
STABILIZED COMPOSITION
|
US7981908B2
(en)
*
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
US7803817B2
(en)
*
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US20070026071A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Qpharma, Llc |
Magnesium salt proton pump inhibitor dosage forms
|
EP1747776A1
(en)
|
2005-07-29 |
2007-01-31 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Pharmaceutical composition comprising granular pantoprazole
|
KR100591142B1
(ko)
*
|
2005-11-04 |
2006-06-20 |
지엘팜텍 주식회사 |
파록세틴을 활성물질로 함유하는 장용성 서방형 정제
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US8486450B2
(en)
|
2005-12-28 |
2013-07-16 |
Takeda Pharmaceutical Company Limited |
Method of producing solid preparation disintegrating in the oral cavity
|
JP2009523784A
(ja)
*
|
2006-01-16 |
2009-06-25 |
ジュビラント・オルガノシス・リミテッド |
酸不安定化合物の安定な医薬製剤およびその製造方法
|
US7579476B2
(en)
*
|
2006-02-24 |
2009-08-25 |
Praktikatalyst Pharma, Llc |
Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
|
JP5457830B2
(ja)
|
2006-04-03 |
2014-04-02 |
オディディ,イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
WO2007138606A2
(en)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
EP1872778A1
(en)
*
|
2006-06-29 |
2008-01-02 |
LEK Pharmaceuticals D.D. |
Stable pharmaceutical composition with rabeprazole sodium
|
US9233092B2
(en)
*
|
2006-07-25 |
2016-01-12 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
|
GB2459393B
(en)
|
2006-10-05 |
2010-09-08 |
Santarus Inc |
Novel capsule formulation for the proton pump inhibitor omeprazole
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
US8352042B2
(en)
*
|
2006-11-28 |
2013-01-08 |
The Alfred E. Mann Foundation For Scientific Research |
Remote controls and ambulatory medical systems including the same
|
US20110174855A1
(en)
*
|
2006-11-29 |
2011-07-21 |
Yakima Products, Inc. |
Vehicle top carriers
|
CN101190208B
(zh)
*
|
2006-11-30 |
2011-11-02 |
石药集团中奇制药技术(石家庄)有限公司 |
一种含有盐酸度洛西汀的药物制剂及其制备方法
|
NZ578204A
(en)
|
2006-12-22 |
2012-05-25 |
Ironwood Pharmaceuticals Inc |
Compositions comprising bile acid sequestrants for treating esophageal disorders
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
RU2010119041A
(ru)
|
2007-10-12 |
2011-11-20 |
Такеда Фармасьютикалз Норт Америка, Инк. (Us) |
Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
|
US8247440B2
(en)
|
2008-02-20 |
2012-08-21 |
Curators Of The University Of Missouri |
Composition comprising omeprazole, lansoprazole and at least one buffering agent
|
US8911787B2
(en)
|
2008-02-26 |
2014-12-16 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
TWI519322B
(zh)
*
|
2008-04-15 |
2016-02-01 |
愛戴爾製藥股份有限公司 |
包含弱鹼性藥物及控制釋放劑型之組合物
|
US20090263475A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Nagaraju Manne |
Dexlansoprazole compositions
|
US20090280173A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Omeprazole Tablets
|
US20090280175A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Proton Pump Inhibitor Tablets
|
AU2009290712A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
CA2753444A1
(en)
*
|
2009-02-23 |
2010-08-26 |
Gopi Venkatesh |
Controlled-release compositions comprising a proton pump inhibitor
|
CN101822671A
(zh)
*
|
2009-03-06 |
2010-09-08 |
信谊药厂 |
雷贝拉唑组合物及其制备方法
|
WO2010151697A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
JP2012531409A
(ja)
|
2009-06-25 |
2012-12-10 |
アストラゼネカ・アクチエボラーグ |
Nsaid関連潰瘍を発症するリスクがある患者の処置方法
|
CN101991543A
(zh)
*
|
2009-08-10 |
2011-03-30 |
杭州赛利药物研究所有限公司 |
一种奥美拉唑肠溶干混悬剂及其制备方法
|
JP2011037787A
(ja)
*
|
2009-08-13 |
2011-02-24 |
Kyorin Pharmaceutical Co Ltd |
塩基性薬物のpHに依存しない安定放出組成物
|
EP2319504A1
(en)
|
2009-11-07 |
2011-05-11 |
Laboratorios Del. Dr. Esteve, S.A. |
Pharmaceutical solid dosage form
|
US20110189271A1
(en)
*
|
2010-02-02 |
2011-08-04 |
Vishal Lad |
Pharmaceutical formulations of acid-labile drugs
|
US20130202688A1
(en)
|
2010-05-04 |
2013-08-08 |
Sunilendu Bhushan Roy |
Delayed release oral disintegrating pharmaceutical compositions of lansoprazole
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
WO2013088109A1
(en)
|
2011-12-16 |
2013-06-20 |
Oxagen Limited |
Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
|
BR112014016085A8
(pt)
|
2011-12-28 |
2017-07-04 |
Pozen Inc |
composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
|
WO2013142370A1
(en)
|
2012-03-19 |
2013-09-26 |
Varghese John |
APP SPECIFIC BACE INHIBITORS (ASBIs) AND USES THEREOF
|
WO2013141827A1
(en)
|
2012-03-21 |
2013-09-26 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Enteric coated solid pharmaceutical compositions for proton pump inhibitors
|
AU2013299656C1
(en)
|
2012-08-07 |
2017-06-22 |
Buck Institute For Research On Aging |
Multi-component formulation for improving neurological function
|
US9623047B2
(en)
|
2012-12-27 |
2017-04-18 |
Photo Finish Supplements, Llc |
Composition and method for improving gastrointestinal health of equine
|
BR112015016917B1
(pt)
|
2013-01-15 |
2022-08-30 |
Ironwood Pharmaceuticals, Inc |
Forma de dosagem oral de retenção gástrica, e, uso de um sequestrante de ácido biliar
|
CN104995176B
(zh)
|
2013-02-12 |
2019-02-22 |
巴克老龄化研究所 |
调节bace所介导的app加工的乙内酰脲
|
CN105980458A
(zh)
|
2013-12-30 |
2016-09-28 |
艾利丹尼森公司 |
用于印刷的薄膜
|
EP2933002A1
(en)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
EP2929885A1
(en)
|
2014-04-11 |
2015-10-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
|
CA2936740C
(en)
|
2014-10-31 |
2017-10-10 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2016126625A1
(en)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
AU2017206077B2
(en)
|
2016-01-08 |
2021-11-18 |
The Regents Of The University Of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
WO2017145146A1
(en)
|
2016-02-25 |
2017-08-31 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
WO2017197177A1
(en)
|
2016-05-12 |
2017-11-16 |
Buck Institute For Research On Aging |
Compounds to promote normal processing of app
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
JP6981088B2
(ja)
*
|
2017-01-27 |
2021-12-15 |
ニプロ株式会社 |
経口固形製剤
|
RU2020100230A
(ru)
|
2017-06-12 |
2021-07-13 |
Глитек Ллс. |
Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a
|
WO2018236955A1
(en)
|
2017-06-23 |
2018-12-27 |
The Regents Of The University Of California |
IMPROVING GABA CAPACITY TO MODULATE IMMUNE RESPONSES
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
JP7061236B2
(ja)
|
2019-01-22 |
2022-04-27 |
エオビアン ファーマシューティカルズ, インコーポレイテッド |
Mtorcモジュレーターおよびその使用
|
CN114569579B
(zh)
*
|
2020-12-02 |
2023-10-31 |
丽珠医药集团股份有限公司 |
肠溶微丸、其制备方法和包含它的制剂
|
CN112516100A
(zh)
*
|
2020-12-31 |
2021-03-19 |
珠海润都制药股份有限公司 |
一种艾司奥美拉唑镁肠溶片及其制备方法
|
ES2924573B2
(es)
*
|
2021-03-18 |
2024-04-24 |
Aora Health S L |
Sistema de administracion en multiples sitios para administracion diferencial en el tracto gastrointestinal
|
CN115715808A
(zh)
|
2021-08-26 |
2023-02-28 |
丽珠医药集团股份有限公司 |
用于干混悬剂的干混悬颗粒及其制备方法和用途
|
WO2023166488A1
(en)
|
2022-03-04 |
2023-09-07 |
Revagenix, Inc. |
Broad spectrum aminoglycosides and uses thereof
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|